sALT629 is an orally active antitubercular agent with potent intramacrophage activity (EC50 = 1.5 µM). sALT629 shows broad-spectrum anti-Mycobacterium tuberculosis (Mtb) activities across four carbon sources, equipotent efficacy against drug-resistant Mtb, and activity against both slow-replicating and nonreplicating Mtb. sALT629 exhibits synergistic activity when combined with oxazolidinone drugs, such as Linezolid (HY-10394) and Sutezolid (HY-10392). sALT629 can be used for the research of tuberculosis[1].
Molekulargewicht:
275.31
CAS Nummer:
[484026-63-3]
Formel:
C13H17N5O2
Target-Kategorie:
Bacterial
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
